SGLT-2 Inhibitors Market Size to Reach USD 31.34 Billion by 2034, Forecasting a Robust 6.24% CAGR Driven by Rising Diabetes Prevalence and Expanding Therapeutic Applications
HealthcareThe global SGLT-2 inhibitors market is on a dynamic growth trajectory, with a projected valuation increasing from USD 18.18 billion in 2025 to USD 31.34 billion by 2034, expanding at a compounded annual growth rate (CAGR) of 6.24%. This surge is primarily propelled by the escalating prevalence of type 2 diabetes worldwide, rapid adoption of […]